In principle, contrast-enhanced magnetic resonance (MR) imaging is capable of non-invasively measuring regional myocardial perfusion, blood volume, extracellular volume, and capillary permeability. In practice, these potential applications are difficult to achieve due to a lack of knowledge concerning the relationship between myocardial contrast concentration and the observed changes in image pixel intensity. Like other imaging modalities, such as PET and CT, the interpretation of myocardial MR contrast enhancement depends on understanding the myocardial kinetics of the tracer. Unlike other modalities, however, interpretation of MR contrast enhancement also requires knowledge of the extent of interaction between the contrast molecule and the myocardial protons (mostly water) from which the MR signal is derived. This interaction is fundamentally linked to myocardial physiology. Historically, most studies of myocardial contrast enhancement have either avoided addressing this interaction by drawing strictly qualitative conclusions or have made broad assumptions concerning this interaction. In this proposal, we present data which demonstrate that myocardial relaxivity (T1) enhancement is directly and profoundly influenced by the diffusion of water between the myocardial vascular, interstitial, and cellular compartments. We also present data which demonstrate our ability to test hypotheses concerning the mechanisms of susceptibility contrast directly in myocardial tissue. We propose a five-year research plan to fully describe both relaxivity and susceptibility myocardial contrast enhancement on the basis of the underlying physiology. We believe that by directly addressing and understanding the effects of myocardial physiology on MR contrast enhancement we will be able to fully evaluate not only the potential of contrast MR to reproduce the successes of PET and CT, but the unique potential of MR contrast enhancement to provide additional physiologic information based on the influence of tissue environment on the MR signal.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HL053411-06
Application #
6043835
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1995-08-01
Project End
2000-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Rehwald, Wolfgang G; Fieno, David S; Chen, Enn-Ling et al. (2002) Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105:224-9
Rehwald, Wolfgang G; Kim, Raymond J; Judd, Robert M (2002) Rapid cine MRI of the human heart using reconstruction by estimation of lines and inhibition of fold-in. Magn Reson Med 47:844-9
Rehwald, W G; Kim, R J; Simonetti, O P et al. (2001) Theory of high-speed MR imaging of the human heart with the selective line acquisition mode. Radiology 220:540-7
Wu, E; Judd, R M; Vargas, J D et al. (2001) Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357:21-8
Klocke, F J; Simonetti, O P; Judd, R M et al. (2001) Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Circulation 104:2412-6
Kim, R J; Wu, E; Rafael, A et al. (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445-53
Fieno, D S; Kim, R J; Chen, E L et al. (2000) Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36:1985-91
Hillenbrand, H B; Kim, R J; Parker, M A et al. (2000) Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 102:1678-83
Kim, R J; Fieno, D S; Parrish, T B et al. (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992-2002
Fieno, D S; Kim, R J; Rehwald, W G et al. (1999) Physiological basis for potassium (39K) magnetic resonance imaging of the heart. Circ Res 84:913-20

Showing the most recent 10 out of 16 publications